The brief

Analyst view

• kIQ Plus uses electrical nerve stimulation for tremor relief in essential tremor and Parkinson's patients.
• 263-patient study: 62% improved tremor severity in 3 months; 54% achieved ≥50% tremor reduction.
• Trinity Capital committed $50M growth capital in April 2026 to scale commercial expansion.

Technical approach

As reported

TAPS therapy

Transcutaneous afferent patterned stimulation

The wrist-worn device delivers electrical pulses mimicking natural nerve patterns, blocking tremor signals. Patterns calibrated per patient.

Personalization

Adaptive calibration

kIQ Plus uses adaptive calibration to detect each patient's response and adjust stimulation patterns, giving patients control over therapy intensity and timing.

Safety

Non-invasive wearable

Worn on the wrist with no surgery. Side effects are mild: wrist discomfort or skin irritation; no serious events in trials.